News analysis for professionals in the cannabis industry

US Major League Baseball makes deal with CBD company Charlotte’s Web

Written by CannIntelligence | 18th November 2022

In an exclusive partnership with Charlotte’s Web, Major League Baseball (MLB) has become the first of the major US sports leagues to sign a deal with a cannabinoid company ...

EIHA's 'reasonable daily intake' sows confusion over novel food applications

Written by Tiziana Cauli | 17th November 2022

CBD isolate producers in the UK are waiting to see whether and how toxicological data released by the European Industrial Hemp Association (EIHA) will affect their novel food applications to the Food Standards Agency (FSA)...

More validated but no light at the end of the tunnel for Efsa’s novel food applicants

Written by Tiziana Cauli | 16th November 2022

Nearly six months after the European Food Safety Authority (Efsa) put novel food assessments for cannabinoids on hold, none of the validated applicants has been able to fill the identified knowledge gaps ...

Sweden's turn to the right may have shut down hopes of liberalisation on cannabis

Written by CannIntelligence | 15th November 2022

Sweden’s general election in September was not good news for cannabis advocates, with the new right-wing bloc minority government likely to take a highly restrictive view, while cannabinoids are not high on its agenda ...

US FDA to ‘advance efforts’ on cannabis research and law with new appointee

Written by CannIntelligence | 14th November 2022

The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency...

With a new bill and a quiet opposition, is Australia closer to legalising cannabis?

Written by CannIntelligence | 11th November 2022

In a first attempt to legalise cannabis through the federal parliament in Australia, the Greens party is in the process of drafting a law for legalisation that will be available for public consultation later this year...

No UK novel food authorisations likely before mid-2023 – and no guarantees

Written by Lorraine Mullaney | 10th November 2022

It’s unlikely that any applications for novel food authorisation of CBD products in the UK will be considered for authorisation before mid-2023 – and being on the list of validated applications is no guarantee ...

$0 to $7.8m in three months – tobacco firm cashes in on cannabis and hemp

Written by Antonia Di Lorenzo | 9th November 2022

US tobacco company 22nd Century Group has enjoyed its first full quarter benefitting from revenue generated by its new hemp/cannabis business arm ...

Mexico cannabis industry doubtful of recreational bill approval before 2024

Written by CannIntelligence | 7th November 2022

Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month ...

US midterm elections: a look at the forecast outcomes and what’s at stake

Written by CannIntelligence | 4th November 2022

The 8th November US midterm elections are just around the corner, and while the Republicans are favoured to win the majority, regardless of the outcome, things will change dramatically ...

Cannabis legalisation set to come out on top no matter who wins US midterms

Written by CannIntelligence | 4th November 2022

Republicans are favoured over Democrats to take control of both chambers of US Congress in the midterm elections, but there are supporters and naysayers among both major parties when it comes to cannabis legalisation ...

Ambitious German startup puts its Signature on Ccell CBD vaping devices

Written by CannIntelligence | 3rd November 2022

German hemp supplier Signature Products is taking a step back to its roots, saying it will step up its marketing of Ccell vape devices that can be filled with CBD extracts ...

Leading Europe? Germany reveals details of plan to legalise recreational cannabis

Written by CannIntelligence | 2nd November 2022

Following an “intensive exchange with experts and interest groups”, the German government has unveiled the key points of its plan to legalise recreational cannabis ...

Austria's ‘Kafkaesque’ politics keep medical cannabis tied up in knots

Written by Lorraine Mullaney | 1st November 2022

Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as "a Kafkaesque nightmare" with over-officious bureaucracy putting pointless hurdles in patients' way ...

Amazon cannabinoid prohibition policy not strictly enforced on UK, US sites

Written by Freddie Dawson | 28th October 2022

Amazon still seems to be laissez-faire about enforcement of ingestible hemp-derived cannabinoid products that appear on its site – and in particular those containing intoxicating hemp-derived cannabinoids (IHDCs) ...

US cannabis company headed by once-convicted ‘kingpin’ now operating legally

Written by CannIntelligence | 28th October 2022

Despite serving 11 years in prison under federal drug kingpin charges, Barry Foy never lost his original vision of bringing cannabis to the people and, eventually, the US caught up with him ...

UK standards authority challenges CBD product marketing disguised as content

Written by Freddie Dawson | 28th October 2022

The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands ...

Canadian cannabis industry lobbies to reduce taxes to save companies

Written by CannIntelligence | 24th October 2022

Canada’s cannabis industry has launched a lobbying blitz, warning that the federal government must act quickly to reduce excise duties and fees on the industry or risk many Canadian cannabis companies going out of business...

UK scientist says medicinal cannabis research in the country lagging behind

Written by Lorraine Mullaney | 21st October 2022

The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area ...

Cannabis & Me – critics fear bias before major psychiatric study gets under way

Written by Lorraine Mullaney | 20th October 2022

A major new study into the impact of cannabis on the brain has attracted controversy and accusations of bias from within the industry before it even begins ...

Cannabis consumption up, cigarette smoking down in latest US Gallup poll

Written by Tiziana Cauli | 18th October 2022

Smoking cigarettes is going out of fashion, but having smoked cannabis is becoming much more common in the US, according to recent research conducted by analytics and polling firm Gallup ...

Medical cannabis could come to Japan after panel recommends legalisation

Written by CannIntelligence | 17th October 2022

Japan has taken a step closer to legalising cannabinoid-based medicines and clarifying restrictions on hemp cultivation, though it is also set to strengthen measures against recreational cannabis use ...

All systems go for medical cannabis in Panama after president signs decree

Written by CannIntelligence | 17th October 2022

Panama has legalised medical cannabis and set up an agency to oversee cannabis industry security. And there is already interest from at least one US company ...

Authors of UK hemp farming report respond to criticisms of impossible goals

Written by Tiziana Cauli | 14th October 2022

The creators of a UK report on hemp that has received criticism from the industry told CBD-Intel they stand by their estimates, but it remains unclear where some of the numbers have come from ...

Inflation-linked French tobacco tax unlikely to apply to smokable hemp

Written by CannIntelligence | 13th October 2022

France has no present plans to include smokable hemp products in a newly proposed inflation-linked tax on smokable tobacco ...

Cannaray's Cellular connection creates confusing combination in cannabinoids

Written by CannIntelligence | 13th October 2022

Cellular Goods and Cannaray have announced a merger that will see Cannaray listed on the London Stock Exchange while also splitting off its CBD brands to work under a new subsidiary ...

Aurora enjoys a profitable new dawn in international medical cannabis markets

Written by Antonia Di Lorenzo | 12th October 2022

Canadian company Aurora Cannabis has seen continued growth in its international business thanks to an increasing presence in emerging medical cannabis markets, notably Germany, the UK, Australia and Poland ...

SNDL/Valens merger set to establish a global leader in adult-use cannabis

Written by Lorraine Mullaney | 11th October 2022

Canadian firms SNDL and Valens are merging in a CAD138m deal that aims to establish one of Canada’s largest adult-use cannabis manufacturers and retailers and a global leader in cannabis products ...

US president Biden pardons federal cannabis offences, looks into scheduling

Written by Freddie Dawson | 10th October 2022

US president Joe Biden has pledged to review how cannabis is scheduled under US law and will pardon all prior federal offences of simple cannabis possession at a fortuitous time ...

Legalisation is ‘least bad solution’ to cannabis consumption in France

Written by CannIntelligence | 7th October 2022

The senator leading a bid to legalise recreational cannabis in France has called legalisation “the least bad solution” to addressing cannabis consumption in the country, and has said he does not expect any measure to...

German officials contest Tilray’s report of meeting on cannabis legalisation

Written by CannIntelligence | 7th October 2022

Tilray Brands’ report of a meeting with government officials over the planned legalisation of adult-use cannabis in Germany has been questioned by some of the officials who were present ...

Italian court will hear appeal against decree limiting use of flowers and leaves

Written by CannIntelligence | 6th October 2022

A request to hear an appeal against Italy’s decree on officinal plants has been accepted by the Regional Administrative Court (TAR) of Lazio ...

'First mover' Xebra expects to start CBD and hemp production in Mexico soon

Written by CannIntelligence | 6th October 2022

Canadian cannabis company Xebra Brands has received legal approval to cultivate and process hemp and manufacture and sell CBD products in Mexico ...

Cannabis may help against opioids – but this latest study doesn’t tell us much

Written by CannIntelligence | 6th October 2022

Reducing opioid dependence is a primary goal of medical cannabis programmes, but there remains a need for rigorous science when making decisions about the interaction between cannabis and opioid use for pain ...

Breakthrough cannabis study finds CBD can reduce psychoactive effects of THC

Written by Lorraine Mullaney | 5th October 2022

A recent study has shown that CBD can reduce the psychoactive effects of THC – a discovery which could advance the clinical application of medical cannabis ...

Bermuda to keep pushing for cannabis legalisation in wake of bill denial by UK

Written by CannIntelligence | 3rd October 2022

Bermudan lawmakers are vexed that UK authorities have not granted assent for a cannabis legalisation bill in the British Overseas Territory despite other commonwealth nations with the UK monarchy as their nominal head of state...

Croatian cannabis and hemp business owners feel the ‘unfair’ weight of the law

Written by Lorraine Mullaney | 30th September 2022

A Croatian hemp producer is challenging the interpretation used by law enforcement to oppose the sale of hemp flower in the country ...

Tobacco giant deepens its interest in cannabis with cash for German firm

Written by Tiziana Cauli | 29th September 2022

Tobacco giant British American Tobacco (BAT) has again bet on the cannabis industry as it looks to diversify its portfolio ...

'Good but needs improvement' – Canada reviews its four-year-old cannabis law

Written by CannIntelligence | 28th September 2022

The Canadian government has launched its long-awaited review of the country’s cannabis law, saying the existing legislation is a good start but needs to be improved ...

Fresh regulation attracts international medical cannabis business to Poland

Written by Lorraine Mullaney | 27th September 2022

International cannabis firms are moving in on the market for medicinal cannabis in Poland in the wake of recent regulatory change in the country ...

French hemp industry trade association wants consortium to fill EFSA’s data gap

Written by Lorraine Mullaney | 21st September 2022

A French hemp trade association believes the consortium approach applied in the initial European novel food application process could again be the solution to the requests for extra data that have stalled assessments ...

HHC and other intoxicating cannabinoids move within legal limbo in Europe

Written by Tiziana Cauli | 16th September 2022

As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise ...

Kushly must pay refunds through FTC over health claims, others may follow

Written by CannIntelligence | 15th September 2022

Kushly is the first – but potentially not the last – CBD company to be forced to provide refunds to consumers through the US Federal Trade Commission (FTC) ...

With midterms coming, what has the Biden administration ever done for us?

Written by Lorraine Mullaney | 15th September 2022

As the US midterm elections approach, questions are being raised about the actions the Biden administration has taken to meet campaign promises regarding drug reform ...

CBD brands hit supermarket shelves as UK market shows mainstream appeal

Written by Lorraine Mullaney | 14th September 2022

Despite the challenges of the market, CBD firms appear to be setting their sights on the UK and have secured some major listings in mainstream supermarkets ...

UK startup secures $12m to Trip further into US 'next generation wellness'

Written by Lorraine Mullaney | 13th September 2022

UK CBD brand Trip has secured a $12m investment to further its growth in the US and other global markets ...

Where the parties stand on cannabis ahead of Italian elections this month

Written by CannIntelligence | 12th September 2022

The right-wing coalition parties which look most likely to triumph in Italy’s coming elections take a uniformly hard line on drug policy – which could be bad news for the cannabinoids industry ...

German hemp farm raided on grounds crop exceeds country’s 0.2% THC limit

Written by CannIntelligence | 12th September 2022

More than two dozen officers carried out a surprise raid on a farm in Dithmarschen on 30th August as part of “an investigation into the joint illegal trade of large quantities of narcotics”, according to the...

Calls for changes in Canadian cannabis laws as strikes cause supply issues

Written by CannIntelligence | 9th September 2022

Canada’s cannabis industry is calling for changes in the way cannabis products are distributed and sold in some parts of the country after labour disputes in two provinces have led to strikes and forced some...

Coming together over cannabis: is support becoming a bipartisan issue?

Written by Freddie Dawson | 8th September 2022

Once mainly the purview of fringe leftists, support for cannabis continues to become more of a bipartisan issue ...

LATEST ALERTS

Written by CannIntelligence | 18th November 2022

Written by Tiziana Cauli | 17th November 2022

Written by Tiziana Cauli | 16th November 2022

Written by CannIntelligence | 15th November 2022

Written by CannIntelligence | 14th November 2022

Written by CannIntelligence | 11th November 2022

Written by Lorraine Mullaney | 10th November 2022

Written by Antonia Di Lorenzo | 9th November 2022

Written by CannIntelligence | 7th November 2022

Written by CannIntelligence | 4th November 2022

Written by CannIntelligence | 4th November 2022

Written by CannIntelligence | 3rd November 2022

Written by CannIntelligence | 2nd November 2022

Written by Lorraine Mullaney | 1st November 2022

Written by Freddie Dawson | 28th October 2022

Written by CannIntelligence | 28th October 2022

Written by Freddie Dawson | 28th October 2022

Written by CannIntelligence | 24th October 2022

Written by Lorraine Mullaney | 21st October 2022

Written by Lorraine Mullaney | 20th October 2022

Written by Tiziana Cauli | 18th October 2022

Written by CannIntelligence | 17th October 2022

Written by CannIntelligence | 17th October 2022

Written by Tiziana Cauli | 14th October 2022

Written by CannIntelligence | 13th October 2022

Written by CannIntelligence | 13th October 2022

Written by Antonia Di Lorenzo | 12th October 2022

Written by Lorraine Mullaney | 11th October 2022

Written by Freddie Dawson | 10th October 2022

Written by CannIntelligence | 7th October 2022

Written by CannIntelligence | 7th October 2022

Written by CannIntelligence | 6th October 2022

Written by CannIntelligence | 6th October 2022

Written by CannIntelligence | 6th October 2022

Written by Lorraine Mullaney | 5th October 2022

Written by CannIntelligence | 3rd October 2022

Written by Lorraine Mullaney | 30th September 2022

Written by Tiziana Cauli | 29th September 2022

Written by CannIntelligence | 28th September 2022

Written by Lorraine Mullaney | 27th September 2022

Written by Lorraine Mullaney | 21st September 2022

Written by Tiziana Cauli | 16th September 2022

Written by CannIntelligence | 15th September 2022

Written by Lorraine Mullaney | 15th September 2022

Written by Lorraine Mullaney | 14th September 2022

Written by Lorraine Mullaney | 13th September 2022

Written by CannIntelligence | 12th September 2022

Written by CannIntelligence | 12th September 2022

Written by CannIntelligence | 9th September 2022

Written by Freddie Dawson | 8th September 2022

Sign up to our newsletter

Start your FREE trial